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Abstract  
Low intensity cognitive behaviour therapy (CBT) including behavioural activation is an 
evidence based treatment for depression, a condition frequently co-occurring with autism. 
The feasibility of adapting low intensity CBT for depression to meet the needs of autistic adults 
via a randomised controlled trial (RCT) was investigated. The adapted intervention (Guided 
Self-Help; GSH) comprised materials for 9 individual sessions with a low intensity 
psychological therapist. Autistic adults (n=70) with depression (PHQ-9 score ≥10) recruited 
from National Health Service adult autism services and research cohorts were randomly 
allocated to GSH or Treatment as Usual (TAU).  Outcomes at 10, 16 and 24 weeks post-
randomisation were blind to treatment group. Rates of retention in the study differed by 
treatment group with more participants attending follow-up in the GSH group than TAU. The 
adapted intervention was well-received, 86% (n=30/35) of participants attended the pre-
defined ‘dose’ of 5 sessions of treatment and 71% (25/35) attended all treatment sessions. 
The findings of this pilot RCT indicate that low intensity CBT informed by Behavioural 
Activation can be successfully adapted to meet the needs of autistic people. Evaluation of the 
effectiveness of this intervention in a full scale RCT is now warranted.  
Keywords: Autism, Adults, Depression, Cognitive Behaviour Therapy 
 
Trial Registration Information:  ISRCTN54650760 assigned 28/09/2016 
http://www.isrctn.com/ISRCTN54650760 
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Introduction 
Autism Spectrum Disorder (ASD), thought to affect 1% of the U.K. adult population (Brugha 
et al. 2011), is characterised by qualitative impairments in social communication and a 
stereotyped, repetitive or restricted pattern of activities, behaviours and interests (APA, 
2013).  High rates of co-occurring mental health conditions are reported across the life-span 
in ASD (e.g. Joshi et al., 2012, Kim et al., 2000; Simonoff et al., 2008) including depression. 
Depression, characterised by persistent sadness and low mood with a range of accompanying 
physical, emotional and behavioural symptoms is a debilitating mental health condition 
(Whiteford et al., 2013). There is evidence that autistic1 people are disproportionately 
affected by depression (Rai et al., 2018) with an estimated current and life-time adult 
prevalence of 23% and 37% respectively (Hollocks et al. 2018).  Effective treatments for 
depression exist. ‘Low intensity’ Cognitive Behaviour Therapy (CBT), to include behavioural 
activation, is recommended as an evidence-based psychological treatment for mild-moderate 
depression (CG90, NICE 2009) in adults.  Low intensity typically refers to low usage of 
specialist therapist time (Bower and Gilbody, 2005) via the provision of evidence based 
information which can be accessed independently (self-help) or with the support of a mental 
health worker (guided self-help), or by the cost-effective use of specialist therapist time such 
as group interventions.    
 
Accessing mainstream psychological therapies can be difficult for autistic people due to 
communication and neurocognitive differences. Additionally, many therapists have not been 
trained in working with autistic people (Cooper et al, 2018).  Clinical guidance for psychosocial 
interventions for co-occurring mental health problems in autism state that the recommended 
intervention for the specific disorder in the general population should be offered with 
adaptations made to meet the needs of autistic people (NICE CG 142, 170).  Where the 
recommended intervention is CBT, strategies to adapt CBT to meet the needs of autistic 
people have been identified in the NICE clinical guidance for autism in adults (NICE CG 142).  
Adapted CBT has been found to be an effective treatment for anxiety co-occurring with 
                                                          
1 Results of a survey of the U.K. autism community highlighted that ‘Autism’, ‘on the Autism Spectrum’ and 
‘Autistic people’ are preferred terms to describe Autism. Here on in, the terms Autism and Autistic people will 
be used (Kenny et al. 2016) 
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autism (see reviews by Weston, Hodgekins & Langdon, 2016; White, Simmons, Gotham et al., 
2018).  A review by White et al., (2018) highlight that there have been few studies 
investigating depression.  Studies of combined anxiety and depression treatment 
(McGilliveray and Evert, 2014; Sizoo and Kuiper, 2017) have reported no convincing evidence 
of an effect of treatment group on depression measures, although sample sizes have been 
small.  There has been one study of an adapted group CBT protocol for depression 
(Santomauro, Sheffield & Sofronoff , 2015) reporting a reduction in depression scores of 20 
autistic adolescents. The authors urge caution in the light of a small sample size and lack of 
control group at follow-up. A study of adults (n=42) randomised to Mindfulness Based Stress 
Reduction (MBSR) or Treatment as Usual reported a significant effect of MBSR on depression 
measures (Spek et al., 2013).  These studies suggest some preliminary evidence in support of 
cognitive-behavioural interventions for depression adapted for autism.  However, there have 
been no adult studies with an exclusive focus on depression investigating autism adaptations 
to low intensity CBT for depression. 
 
Low intensity CBT may offer benefits for the treatment of depression co-occurring with autism 
for a number of reasons. Firstly, Behavioural Activation (BA) is the recommended treatment 
model for low intensity CBT for depression.  BA, informed by learning theory, is an approach 
developed by Martell, Addis and Jacobsen (2001) which aims to change an individual’s 
behavioural repertoire to increase opportunities to access positive reinforcement and 
thereby reduce depression.  These aims are primarily achieved through Activity Scheduling, 
whereby the individual plans and schedules specified activities in their weekly routine based 
on a detailed analysis of their current behaviour.  People are encouraged to become more 
aware of the triggers for low mood and consequences of a range of behaviours and to then 
use this information to make changes in line with individual goals.  BA may be highly suited 
as an intervention for depression in autistic adults.  Firstly, a restricted, repetitive, 
stereotyped pattern of behaviour, interests and activities is a core characteristic of autism. It 
is possible that when depressed, autistic people do not easily generate shifts in routines, 
behaviours and thought patterns towards activities and actions that may offer increased 
access to pleasure and a sense of achievement, and thus reduce depression.  This tendency 
towards restricted activities and interests, including repetitive thinking, may form part of the 
behavioural maintenance cycle of depression symptoms in autism with some research 
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evidence  in support of this (e.g. Gotham et al., 2014).  Secondly, the well-documented 
executive function differences in autism (Demetriou et al., 2018) mean generating and 
implementing novel planned behaviour and activity can be compromised in autistic people. 
To this end, BA adapted for the needs of autistic people may be helpful in broadening 
behavioural and thought repertoires to ultimately improve depressed mood.   
 
Additionally, adaptations to CBT to meet the needs of autistic people recommend the use of 
written information with visual aides (NICE, 2012).  The provision of written information is at 
the core of a low intensity intervention.  Adapting the written information to meet the needs 
of autistic people means that low intensity psychological therapists who do not have 
extensive experience in working with autistic adults have less elements of their therapeutic 
practice to adapt i.e. some of the key adaptations are delivered through the materials. This 
may confer some advantages to a low intensity intervention over individual talking therapy 
which is solely verbally mediated.  In a survey of CBT therapists, confidence in adapting 
practice for autistic people was significantly associated with level of therapist training (Cooper 
et al., 2018). Low-intensity interventions were developed with the aim of disseminating 
evidence based practice to mental health professionals from a range of backgrounds. This 
may be highly pertinent to autistic adults who can receive support and healthcare from a 
range of professionals.  
 
The present study, developed in response to a themed call from the Health Technology 
Assessment (HTA) panel of the National Institute of Health Research (NIHR) (HTA 14/43), 
aimed to: 
(i) Develop a low-intensity intervention for depression based on NICE guidance for 
adults, adapted for Autism, including training materials for low intensity 
psychological therapists  
(ii) Investigate the feasibility and patient and healthcare worker acceptability of the 
low intensity intervention 
(iii) Estimate the rate of recruitment and retention for a fully-powered randomised 
controlled trial (RCT)  
(iv) Identify the most appropriate outcome measure for a fully-powered RCT  
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Methods  
Study Design 
The feasibility study comprised a randomised controlled trial, with a nested qualitative study. 
Detailed information about the study methods are available in the published protocol (Russell 
et al., 2017). In brief, participants were randomised to one of two groups: (1) an adapted low 
intensity CBT intervention for depression Guided Self-Help (GSH); or (2) Treatment as Usual 
(TAU).  The nested qualitative study will be reported in full elsewhere. Ethical approval for the 
study was granted by WALES REC 3 (IRAS project ID: 191558) and permissions to carry out the 
study was obtained from the National Health Service (NHS) trusts involved. Trial registration 
was assigned (ISRCTN54650760).  
Participants 
Eligible participants were adults (≥18 years old) with a diagnosis of Autism Spectrum Disorder 
(ASD) and current depression defined as PHQ-9 score ≥10. Excluded were those with: a risk 
of suicide such that clinical need exceeded a low intensity intervention; current alcohol or 
substance-use dependence; untreated epilepsy; a history of psychosis; or who had received 
≥6 sessions of individual CBT in the last 6 months. Also excluded were individuals who were 
unable to understand the study materials due to language or literacy levels.   
Recruitment 
Potential participants were introduced to the study by clinicians in two NHS adult autism 
services or by letter to autistic adults registered on an NHS research opportunity (Bristol) and 
a U.K. autism cohort study, across two geographical regions of England (Bristol, Bath and 
North East Somerset; and Northumberland, Tyne and Wear). The recruitment procedure is 
described in full in the published protocol (Russell et al., 2017). In brief, those interested in 
the study who gave permission to be contacted by the research team were provided with full 
study information and if they expressed interest had a telephone screening according to the 
inclusion and exclusion criteria. The Patient Health Questionnaire-9 (PHQ-9) (Kroenke and 
Spitzer, 2002) could be completed as part of the telephone screening or by return post if 
preferred. The PHQ-9 is a reliable and valid nine-item self-report measure of depression 
commonly used in primary care settings. A PHQ-9 score ≥ 10 conferred eligibility for the study 
which was further confirmed at a face to face meeting.  The Clinical Interview Schedule-
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Revised (CIS-R) (Lewis et al., 1992) was administered at this meeting to capture current 
depression. The CIS-R is a widely used, well validated diagnostic instrument which generates 
ICD-10 psychiatric diagnoses.  Fully informed consent in writing was obtained from eligible 
participants willing to take part in the study. A series of open questions about participation in 
the study ensured consent was fully informed.  
Randomisation 
Eligible consenting participants were randomised to receive (1) GSH or (2) TAU.  Allocation 
was concealed from recruiting researchers through use of a remote computerised 
randomisation service. Allocation was stratified by site (Bristol, Bath and North East Somerset 
or Newcastle, Tyne and Wear NHS regional centre and minimised by depression severity 
(mild-moderate: PHQ-9 score: between 10 to 15 or moderate-severe: PHQ-9 score between 
16 to 27) and current use of antidepressant medication (yes or no). Participants were 
informed about the outcome of randomisation by the trial manager.  
Intervention 
GSH comprised materials for nine weekly sessions which participants could work through with 
the support of a ‘coach’ i.e. a low intensity psychological therapist. The intervention (see 
Russell et al., 2017), based on Behavioural Activation (BA), was tailored to meet the needs of 
autistic people. The feedback of two autistic adults informed two iterations of the session 
materials.  The materials had a consistent structure and format. Visual images were used to 
supplement written accounts of psychological principles. Emotional literacy and executive 
function difference were supported throughout. The aim of the intervention was to facilitate 
learning about links between situations, behaviours and feelings, and use this learning to 
schedule activities promoting positive feelings.  The initial session was an orientation to 
guided self-help, the role of the ‘coach’ and an opportunity for the coach to learn about 
individualised needs for autism specific adaptations.  Individual goal-setting for the 
intervention was completed at the end of this session.  Sessions two and three focused on 
mapping daily situations and behaviours using a visual map and diary sheet.  Session four took 
an educational approach to noticing and rating positive feelings. Session five brought together 
information about situations, behaviours and feelings.  This information was used to schedule 
activities to increase opportunities for positive mood which were also in line with an 
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individual’s goals and Maslow’s hierarchy of needs.  An individual’s needs for support and 
prompts to implement the activity schedule plans were also discussed. Recording information 
about situations, behaviours and feelings using the map and/or diary sheets was a consistent 
between-session task. Sessions six, seven and eight were spent refining activity scheduling to 
extend to novel situations and novel behaviours if appropriate.  Session nine was a review of 
treatment principles and goals.  To simulate routine clinical practice, the PHQ-9 and GAD-7 
were administered at the start of each session.   The intervention was delivered face-to face, 
weekly in outpatient clinic settings and was intended to be delivered across 10 weeks. 
However, participant and/or coach availability as a result of factors such as illness, holidays 
and educational/work commitments meant that 16 weeks presented a more realistic time-
frame for delivery of the intervention.  Each sessions lasted between 30 and 45 minutes, with 
the exception of the initial planning session which could last up to 90 minutes. The final two 
sessions could be delivered by telephone according to patient preference. Engagement with 
five sessions constituted a treatment ‘dose’ as the main therapeutic principles had been 
presented at that stage.  
GSH coaches were graduate level psychologists with foundation knowledge of CBT who 
attended 15 hours of training in the intervention and working with autistic people. Coaches 
received weekly supervision (1 hour in duration) from the research clinical psychologists who 
had designed the intervention (AR, SB and KC). A manual for the coaches accompanied the 
session materials.   
Treatment as Usual  
There were no constraints on TAU.  Participants randomised to TAU were signposted to 
local psychological therapy treatment services and this was also communicated to 
participants’ GPs by letter, along with their PHQ-9 score.   
 
Data collection and Outcome Measurement 
Outcomes were measured at 10, 16 and 24 weeks post-randomisation by researchers blind 
to treatment group.  Self-report outcome measures were ordinarily completed via a 
computerised survey at a face to face meeting, remotely using an electronic link or by post 
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according to individual preference. Where follow-up was not face to face, the interview 
measure of depression (see below) was conducted by telephone.  
There is some evidence about the reliability and validity of two self-report  measures to screen 
and identify depression  in the autistic population (Cassidy et al., 2018) but no information 
about whether measures are sensitive to change.  Therefore, one of the objectives of this 
feasibility study was to identify the most appropriate outcome measure and hence three 
depression measures were included and no primary outcome measure specified. 
Qualitative interviews about the experience of being in the study and the experience of the 
intervention were conducted by telephone after the 10 week follow-up. 
 Depression Measures:  
PHQ-9 (Kroenke and Sptizer, 2002): This is a reliable (Cronbach’s α=0.83-0.94) and valid nine-
item self-report measure of depression commonly used in primary care settings. To the 
authors’ knowledge the psychometric properties of the scale have not been investigated with 
the autistic population.   
Beck Depression Inventory-II (BDI-II) (Beck et al., 1996): This is a widely used, 21 item self-
report measure of depression found to be reliable (Cronbach’s α=0.92) for outpatients. A 
validation study of 50 young autistic people reported good internal consistency on the BDI-II 
(Cronbach’s alpha=0.90) (Gotham et al., 2015). 
GRID-Hamilton Rating Scale for Depression (GRID-HAMD-17) (Williams et al., 2008): This is a 
17-item clinician administered interview which has been found to be reliable and valid in the 
general population but to our knowledge has not been investigated in the autistic population.  
GRID-HAM-D interviews were audio recorded with participant consent for the purposes of 
inter-rater reliability. Interviewers were trained in GRID-HAM-D administration using face to 
face training with demonstrations and role-plays. The first six HAM-D interviews by each 
interviewer were subject to a second independent rating, (excluding items 8 and 9 which 
require face to face assessment i.e. observation of psychomotor retardation and agitation) to 
establish reliability of each assessor.  To establish reliability across the study, a random sample 
(20%) of GRID-HAMD recordings were independently rated.  
Other Measures 
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The feasibility of capturing a broad range of outcomes was considered due to the range and 
frequency of co-occurring conditions associated with autism. The measures are described in 
more detail in the published protocol (Russell et al., 2017) and include well validated 
measures of anxiety (General Anxiety Disorder-7, Spitzer et al., 2006; Cronbach’s α=0.92); 
obsessive compulsive symptoms (Obsessive Compulsive Inventory-Revised (OCI-R), Foa et al, 
2002) –  excellent internal consistency for use of the OCI-R has been reported in autistic adults 
(Cronbach’s α=0.92); Cadman et al., (2015); positive and negative affect (Positive and 
Negative Affect Schedule (PANAS) Crawford and Henry, 2004) (positive scale cronbach’s 
α=0.89, negative scale cronbach’s α=0.85); the Work and Social Adjustment Scale (WSAS) 
Mundt et al, 2002) (Cronbach’s α=0.7-0.94);  quality of life and health (EQ-5D-5L: Herdman et 
al., (2011) and SF-12: Ware et al., (1996) were completed at each outcome point.  
We also assessed the feasibility of data collection on statutory health and voluntary service 
use with a self-report questionnaire. We also accessed GP and secondary care records for 
information about health care consultations and prescriptions.  This data would inform the 
collection of resource use information needed for an economic evaluation alongside a large-
scale trial. 
Adverse events were captured using a standardised operating procedure and reported to the 
study Data Monitoring and Ethics Committee (DMEC). 
Sample Size 
As this was a feasibility study not designed to test effectiveness, there was no formal sample 
size calculation. Therefore, we aimed to recruit 70 participants to inform decision making 
about the practical issues of conducting a fully-powered RCT.  
Statistical Analysis 
Analysis and reporting of this trial was in accordance with the CONSORT guidelines. A pre-
defined analysis plan was agreed with the Data Monitoring and Ethics Committee (DMEC). All 
analyses were conducted in Stata version 15.  
 
The characteristics of those randomised were described using appropriate descriptive 
statistics. The primary interest was in estimating recruitment and retention rates for a large-
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scale trial. Therefore, we calculated: (1) the proportion of autistic adults consenting to the 
study; (2) the proportion completing the baseline assessment and entering the randomised 
phase; (3) for those in the intervention group, the number of guided self-help sessions 
attended and the proportion completing five or more sessions; (4) the proportion completing 
follow-up assessments at 10, 16 and 24 weeks post-randomisation. The completeness of data 
for each outcome measure and time-point was compiled.   
 
To identify the most appropriate outcome measure for a fully-powered RCT we sought to 
evaluate two widely used self-report measures of depression against a clinician administered, 
interview measure of depression (HAM-D).  We considered the interview measure (HAM-D) 
as the benchmark measure of depression. To ensure reliability of the HAM-D as the 
benchmark depression measure, we examined inter-rater agreement between continuous 
scores using Intra-Cluster Correlation (ICC) from a two-way mixed effect, repeated measures 
ANOVA model (observations are random, outcome measure instrument is fixed) for 20% of 
all HAM-D interview recordings.  We then examined the sensitivity to change (defined as a 
binary outcome of at least 50% improvement in symptoms of the HAM-D at time point of 
measurement of the primary outcome compared to baseline) using Receiver Operating 
Characteristic (ROC) curve analyses separately for the two self-report depression measures.   
 
We also compared the continuous scores on the depression outcome measures only (HAM-
D, PHQ-9, BDI-II) between groups. The data on service use were described using appropriate 
descriptive statistics including completeness of data and source of data (self-report or medical 
records where applicable).   
 
Results    
Feasibility of recruitment 
Participant recruitment began in October 2016, the final participant was randomised in 
September 2017 and the final follow-up measures completed in March 2018.  Recruitment 
via the four recruitment pathways varied (Web Appendix 1); in Bristol NHS adult autism 
service, 27% (n = 22/82) of patients sent study information were randomised, compared with 
18% (n = 28/154) in the North-East NHS autism service. Differences in clinic procedures such 
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as pre-clinic screening, post-diagnostic groups and use of a retrospective clinic list might 
account for this variation.  In terms of the other recruitment pathways, 4% (n = 13/326) and 
12% (n=7/59) of people from the Bristol NHS research opportunity and U.K. autism cohort 
study respectively who were sent information about the study were randomised.  Across all 
recruitment pathways, in total, 21% (n = 133/621) of autistic adults introduced to the study 
expressed interest in contact with the research team and of these,  71% (95/133) completed 
the screening for potential eligibility for the study.  
Twenty-five percent (n = 24/95) of adults who were interested in the study and assessed were 
not eligible (see Figure 1); 40% (n = 10/25) had a PHQ-9 score of less than 10, 20% (n = 5/25) 
were assessed to be at risk of suicide and 40% (n = 10/25) due to other reasons. One 
participant did not give consent (n = 1/95, 1%). Seventy participants were randomised; 35 to 
Guided Self-Help and 35 to Treatment-As-Usual.  
Figure 1 about here 
 
 
Baseline Characteristics 
Participants in the GSH and TAU groups were similar in terms of demographic characteristics 
and study measures at baseline (Table 1 numerical denominators vary across measures due 
to missing data).   Levels of depression were relatively severe; the mean PHQ-score was 15.8 
(SD 4.1, n = 70), with fifty-five percent (n = 38/69) of participants meeting ICD-10 criteria for 
a primary diagnosis of a moderate or severe depressive episode. Sixty-seven percent (n = 
35/52) had been depressed for two years or more and 46% of participants (n = 32/70) self-
reported taking antidepressant medication. The majority of participants in both groups had 
prior experience of psychological therapy.   
Feasibility of the Guided Self-Help intervention 
Eleven percent (n=4/35) of participants randomised to GSH withdrew from treatment. Of 
these, two participants did not attend any treatment sessions and withdrew from the study, 
one participant attended two GSH sessions and withdrew from the study and one participant 
attended 5 GSH sessions but did not withdraw from the study, completing all outcome 
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measures.   Sixty-three percent (n = 20/32) of participants who started GSH did so within two 
weeks of randomisation.  Ninety-one percent (n = 32/35) of participants attended at least one 
session of GSH and 71% (n=25/35) attended all nine sessions. One participant was unable to 
attend any sessions due to ill-health but did not withdraw from the treatment or the study. 
The mean number of treatment sessions was 7.6 (SD 2.9, n = 35) with 86% (n = 30/35) 
completing the pre-specified “dose” of treatment i.e. 5 sessions. By 10 weeks, 31% (10/32) 
had completed the intervention, by 16 weeks 73% (23/32) had completed the intervention 
and by 24 weeks, 84% (27/32) had completed treatment.  Information about reasons for 
spacing of appointments and rate of attendance was not systematically collected. However, 
participant and coach availability due to holidays or ill-health, adverse events such as 
homelessness, organisational difficulties and the impact of depression on behavioural 
motivation were factors which affected attendance and pacing of appointments such that 16 
weeks presented a more practicable treatment window. 
 
The intervention was delivered face-to-face for most participants. A minority accessed the 
intervention via Skype (n = 3/32, 9%) due to difficulties attending face-to-face treatment for 
health and childcare reasons.    
Treatment as Usual  
Of those participants in TAU who attended follow-up and provided information across the 
duration of the study, 15 (63%) were prescribed antidepressant medication which is a small 
increase from the percentage (n=18/51%) reporting this at baseline, 9 (38%) were offered 
primary care mental health support and 1 participant received support from secondary 
mental health care services.  
Adverse Events 
Four  adverse events were reported during the course of the study, one participant in the 
TAU group and three in the GSH group. Adverse events comprised involvement in a road 
traffic accident, medical investigations, a period of temporary homelessness and increased 
vulnerability due to deterioration in housing. None were related to the intervention or were 
considered serious adverse events.  
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Rate of Retention  
Figure 1 shows the flow of participants through the study.  Seventeen percent (n = 6/35) of 
participants allocated to TAU and nine percent (n = 3/35) of participants allocated to GSH 
withdrew from the trial.  The majority (n=5/6) of participants withdrawing from TAU did so 
soon after randomisation. The timing of withdrawals in the GSH group was shortly after 
randomisation (n=2) and before the final follow-up (n=1).   
The rate of retention in the study differed by treatment group (see Table 2).  Follow-up was 
higher in the GSH group at 10, 16- and 24-week follow-up, with just 54% of the TAU group 
completing 16-week outcome measures compared to 86% in the GSH group.  
Table 2 about here 
In respect of mode of follow-up, 75% (n=46/61) participants attended a face-to-face meeting, 
21% (n=13/61) opted to complete self-report follow-up measures remotely using an 
electronic link (21.3%, n=13/61) or by post (3.3%, n=2/61). Those completing measures at 
baseline and follow-up generally completed the depression measures and the full set of 
secondary outcome measures.  
 
Acceptability of depression measures and choice of primary outcome  
Given that only 31% of participants had completed the intervention by 10 weeks post-
randomisation, it would be more appropriate to measure the primary outcome at a later time 
point for a large-scale trial. Therefore, the acceptability of the three depression outcome 
measures (PHQ-9, BDI-II and HAM-D) was assessed at 16 weeks when 72% of GSH participants 
had completed treatment.  At this time point, seventy eight percent (n=38/49) of participants 
completed both the PHQ-9 and HAMD-D, while 69% (n=34/49) of participants completed the 
BDI-II.  
Table 3 shows the mean scores on the depression and other outcome measures by group at 
10, 16- and 24-weeks post-randomisation.  
The sensitivity to change of the self-report measures of depression (PHQ-9 and BDI-II) with 
the observer-rated HAM-D was assessed.  At the beginning of the study, 14 HAM-D 
assessments administered by two raters were double-rated independently with inter-rater 
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agreement on total HAM-D scores very high (> 90%), with some variability in inter-rater 
agreement at the individual item level (e.g. 37.5% on depressed mood and 87.5% for 
insomnia). Additional raters were trained in HAM-D administration across the duration of the 
study and inter-rater agreement on the 28% of HAM-D administrations assessed at the end 
of the study indicated poor reliability. Only one pair of assessors had a Cohen’s kappa of more 
than 0.8 (range 0.1 to 0.8), which had been pre-specified as acceptable.  Given these data, the 
planned sensitivity to change analyses of the two self-reported depression measures were 
considered inappropriate.  
Feasibility of data collection on resource use 
Rates of completion of the questionnaire were at 80% for the majority of items (see Web 
Appendices 2 and 3). During the study, participants used antidepressant medication (43% to 
66%), attended an NHS outpatient or community mental health team clinic for mental health 
problems (11% to 49%) and/or visited their GP (26% to 46%).  Twenty nine percent of 
participants also used other medication for mental health conditions. Participants did not 
report any overnight stays in an NHS hospital, or visits to a private hospital or clinic due to 
mental health problems, and rarely attended an A&E department, an out-of-hours clinic or 
NHS walk-in centre. Twenty-three percent of participants had counselling or talking therapy 
during the trial outside of the trial intervention. Participants used a variety of different types 
of help for mental health problems including support groups and received help around or 
outside of the home. Twenty-seven percent of participants took time off work due to mental 
health problems.  Many participants attended a social group (24%) or drop-in service (26%) 
for autistic adults. Participants rarely had a home visit from any other professional (for any 
medical condition). Thirty percent of participants paid NHS prescription charges and 43% 
received disability payments. Participants did not come into contact with the criminal justice 
system (either as a victim or as a potential suspect).   
It was possible to compare data from self-reported questionnaires and electronic medical 
records (EMR) only for those participants from the Bristol region due to issues with collecting 
EMR data from the North-East site. There was a lack of concordance between the self-
reported and the EMR data for those variables where both sources of information were 
available (Web Appendix 3).  
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Discussion 
It was feasible to develop and implement a low intensity intervention for depression for 
autistic adults and recruit the planned number of participants into a RCT. Rates of retention 
differed across the study according to treatment group.  Noticeably fewer people remained in 
the TAU group of the study with the majority withdrawing directly after randomisation. It was 
difficult to engage these participants in the qualitative interview study to ascertain the 
reasons why.  One participant did agree to be interviewed and stated the outcome of 
randomisation was the reason for withdrawal. More than 70% of participants had prior 
experience of talking therapy which may account for the potential lack of clinical equipoise.  
Participants in the qualitative study talked about wanting to try something ‘new’ (Russell et 
al., Health Technology Assessment, in press).  The findings of the qualitative study indicated 
that participants understood the information provided about the trial and the randomisation 
procedure.    
Depression in this sample of autistic adults was relatively severe and persistent.  The majority 
of participants had depression for two years or more. The relative severity of the depression 
in this sample raises questions about the appropriateness of a low intensity intervention.  A 
number of individuals were assessed as not eligible to take part in the study because of the 
severity of illness and were referred for higher intensity treatment.  Taken together, these 
findings highlight the range of clinical need in this group.  
There was good engagement with the adapted low intensity intervention and the majority of 
participants attended all sessions. Rates of withdrawal from the treatment group are similar 
to those reported by other trials of psychological interventions with autistic adults (e.g. 
Langdon et al., 2016).  Sixteen weeks presented a realistic window for treatment delivery.  
The therapist guided self-help intervention, with nine individual sessions of up to 45 minutes 
could be construed as at the upper limit of ‘low-intensity’.  In addition to session duration, 
coaches made practical adjustments to accommodate the needs of individual participants 
such as appointment reminders and flexibility around timings and frequency of sessions. The 
findings of the qualitative interview study (Russell et al., Health Technology Assessment in 
press) indicated that the intervention was well-received by participants.  
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The set of measures used in the study captured a broad range of outcomes with the aim of 
characterising the sample and the feasibility of investigating the potential for co-occurring 
conditions to influence treatment outcome in a larger study. In the GSH group, the majority 
of participants completed the full set of measures, but the high rate of attrition in the TAU 
group impacts on our ability to learn from these.  To our knowledge this is the first adult study 
of a psychological intervention using a randomised trial design with treatment as usual as a 
comparator. Measures to improve participant engagement with future trials of similar design 
may benefit from co-production of study information and newsletters as well as including 
incentives for follow-up.   
In respect of findings related to measurement in this study, two main issues were identified.  
Firstly, it was not possible to conduct the planned analyses to identify which of the two self-
report measures of depression was most sensitive to change.  Poor inter-rater reliability of 
the ‘benchmark’ interview measure was at the root of this.  The expert raters commented 
valid administration of the HAM-D in autistic adults was difficult if interviewers were relatively 
new to the client group. Open questions did not always work well, in particular questions 
about emotional states. Less experienced interviewers lacked the confidence to be more 
directive at interview e.g. follow-up with direct/closed or forced-choice prompts to elicit the 
information needed to rate items.   The two self-report measures of depression were well-
aligned.  There was some anecdotal evidence from researchers that participants preferred 
the format of the BDI-II with item sets of descriptive statements from which to choose.  
Researchers described how some participants struggled to complete the PHQ-9 with the need 
to rate their experiences using temporal categories requiring a degree of judgement e.g. 
distinguishing between ‘not at all’ and ‘several’ days.  Two studies have reported the BDI-II to 
be an adequate screening tool for depression in autism (Cederlund et al., 2010; Gotham et 
al., 2015). A systematic review of the use of depression measures in autistic adults (Cassidy 
et al., 2018) found one study investigating psychometric properties of depression measures 
met eligibility criteria for the review. This study (Gotham et al., 2015) reported the BDI-II to 
have good internal consistency, adequate sensitivity and specificity and good convergent 
validity when administered to autistic people.  The psychometric properties of the PHQ-9 for 
use in autistic adults have not been investigated.  There were no studies reporting the 
sensitivity to change of any measures. A number of clinical trials with autistic children and 
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adults have reported treatment effect sizes to vary according to rater. The results of a meta-
analysis report how informant and clinician ratings show medium-large effect sizes when 
compared with small effects of treatment as reported by patients themselves (Weston and 
Hodgekins, 2016).  Issues such as alexithymia (e.g. Berthoz and Hills, 2005) and the co-
existence of multiple problems may mean discriminating change at the individual symptom 
level is difficult. Nonetheless, symptom change is reported across a number of measures 
including the depression measures in the present study, suggesting that the use of self-report 
in adults who are able to do so may be viable as part of a larger treatment study.  On the basis 
of the research evidence and the findings of this study, we conclude that the Beck Depression 
Inventory-II (BDI-II) presents as the most suitable outcome measure for a future randomised 
controlled trial.  
Secondly, there was a discrepancy between self-report and EMR reports about a number of 
variables including antidepressant prescriptions and primary and secondary healthcare 
attendance. Discrepancies were not in a single direction. It is likely that practice records are 
the most accurate record of primary care attendance and antidepressant medication. 
However the interface between primary and secondary care in respect of the latter may make 
it more difficult to accurately capture prescriptions.  
This study was not powered to detect differences between the treatment groups. However, 
review of scores on the main measures indicate that the intervention merits further 
investigation.  
In conclusion, it was feasible to develop a low intensity cognitive behavioural intervention 
adapted for the needs of autistic people which was time-limited, structured, protocol-driven 
and used the principles and elements of Behavioural Activation including functional analysis, 
attending to behaviours that increase positive affect, activity scheduling and consolidation of 
learning to sustain treatment gains. Differences to standard treatment comprised greater 
therapist flexibility about location, timing and spacing of appointments, a longer introductory 
session to build working alliance, increased awareness of and literacy about positive mood 
via visual material, use of spatial cognition to link behavioural antecedents and consequences 
and linking behaviours and positive affect to personal needs to encourage self-regulation and 
self-care.  These adaptations to standard treatment are in line with those recommended by 
U.K. clinical guidance (NICE CG142) for adapting psychosocial treatments for autism and also 
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align well with the outline of candidate mechanisms of action for therapeutic intervention 
proposed in the Research Domain Criteria (RDoC) matrix (e.g. White, et al., 2018). The 
intervention was well-received and it was feasible to run a clinical trial with a randomised 
design. We now need evidence from a fully-powered, large scale trial to inform guidance as 
to whether this low-intensity psychological intervention is an effective treatment for autistic 
adults with co-occurring depression.  
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